Clinical Trials Sponsored by Aevum Zenth Conglomerate

Showing 1-10 of 253 trials · Sorted by Start Date (Newest)
NCT Identifier Trial Title Phase Status Conditions Start Date
NCT06388291 Biomarker Validation for AZN-5509 in Solid Tumor Metastasis Phase 1 Not Yet Recruiting Neoplasm Metastasis; Carcinoma; Tumor Biomarkers 2024-06-01
NCT06310442 CAR-T Cell Therapy (ZENTH-CD19) for Relapsed/Refractory B-Cell ALL Phase 2 Recruiting Acute Lymphoblastic Leukemia; Hematologic Neoplasms 2024-03-11
NCT06294105 Gene Therapy Using AAV9 Vector for Duchenne Muscular Dystrophy Phase 2 Recruiting Duchenne Muscular Dystrophy; Muscle Weakness; Dystrophinopathy 2024-01-22
NCT06245108 Real-World Evidence Study of AZN-9921 in Chronic Hepatitis C Phase 4 Completed Hepatitis C, Chronic; Liver Cirrhosis; Viral Hepatitis 2023-12-10
NCT06211593 Phase 3 Randomized Trial of AZN-1174 vs Standard of Care in Type 2 Diabetes Phase 3 Recruiting Diabetes Mellitus Type 2; Metabolic Syndrome; Glucose Intolerance 2023-09-19
NCT06182934 Efficacy and Safety of AZN-4421 in Advanced Non-Small Cell Lung Cancer Phase 3 Recruiting Lung Neoplasms; NSCLC; Oncogene-Addicted Cancers 2023-08-14
NCT06102744 Phase 2 Trial of Dual PI3K/mTOR Inhibitor in Pediatric Brain Tumors Phase 2 Recruiting Glioma; Medulloblastoma; Pediatric Neoplasms 2023-05-14
NCT06045881 Longitudinal Safety Study of Bioengineered Cardiac Patches Phase 1 Enrolling by Invitation Myocardial Infarction; Heart Failure; Regenerative Medicine 2023-02-28
NCT05988217 AI-Guided Dose Optimization for AZP-889 in Alzheimer's Disease Phase 1 Completed Alzheimer Disease; Mild Cognitive Impairment; Neurodegeneration 2022-11-05
NCT05877420 Neuroregenerative Effects of Stem Cell-Derived Oligodendrocytes in MS Phase 2 Completed Multiple Sclerosis; Neuromyelitis Optica; Demyelinating Diseases 2022-06-07
ClinicalTrials.gov does not recommend, endorse, or certify any clinical trial or sponsor. All information displayed is provided by the trial sponsor and is subject to change. Data synchronization timestamp: 2024-11-15T08:30:00Z.